131 related articles for article (PubMed ID: 9209568)
1. Can the sensitivity of the Alzheimer's Disease Assessment Scale be increased?
Mattes JA
Am J Geriatr Psychiatry; 1997; 5(3):258-60. PubMed ID: 9209568
[TBL] [Abstract][Full Text] [Related]
2. The Alzheimer's Disease Assessment Scale: evaluation of psychometric properties and patterns of cognitive decline in multicenter clinical trials of mild to moderate Alzheimer's disease.
Doraiswamy PM; Kaiser L; Bieber F; Garman RL
Alzheimer Dis Assoc Disord; 2001; 15(4):174-83. PubMed ID: 11723368
[TBL] [Abstract][Full Text] [Related]
3. The ADAS-cog in Alzheimer's disease clinical trials: psychometric evaluation of the sum and its parts.
Cano SJ; Posner HB; Moline ML; Hurt SW; Swartz J; Hsu T; Hobart JC
J Neurol Neurosurg Psychiatry; 2010 Dec; 81(12):1363-8. PubMed ID: 20881017
[TBL] [Abstract][Full Text] [Related]
4. Semantic memory impairment in the earliest phases of Alzheimer's disease.
Vogel A; Gade A; Stokholm J; Waldemar G
Dement Geriatr Cogn Disord; 2005; 19(2-3):75-81. PubMed ID: 15572875
[TBL] [Abstract][Full Text] [Related]
5. Effects of educational background on verbal fluency task performance in older adults with Alzheimer's disease and mild cognitive impairment.
Kawano N; Umegaki H; Suzuki Y; Yamamoto S; Mogi N; Iguchi A
Int Psychogeriatr; 2010 Sep; 22(6):995-1002. PubMed ID: 20602860
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer's Disease Assessment Scale: reliability and validity in a multicenter clinical trial.
Weyer G; Erzigkeit H; Kanowski S; Ihl R; Hadler D
Int Psychogeriatr; 1997 Jun; 9(2):123-38. PubMed ID: 9309486
[TBL] [Abstract][Full Text] [Related]
7. Screening for amnestic mild cognitive impairment and early Alzheimer's disease with M@T (Memory Alteration Test) in the primary care population.
Rami L; Molinuevo JL; Sanchez-Valle R; Bosch B; Villar A
Int J Geriatr Psychiatry; 2007 Apr; 22(4):294-304. PubMed ID: 16998781
[TBL] [Abstract][Full Text] [Related]
8. Executive function impairment in community elderly subjects with questionable dementia.
Lam LC; Lui VW; Chiu HF; Chan SS; Tam CW
Dement Geriatr Cogn Disord; 2005; 19(2-3):86-90. PubMed ID: 15572877
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of preclinical Alzheimer's disease in a clinical setting.
Visser PJ; Verhey FR; Ponds RW; Jolles J
Int Psychogeriatr; 2001 Dec; 13(4):411-23. PubMed ID: 12003248
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer Disease Assessment Scale: a subtest analysis.
Zec RF; Landreth ES; Vicari SK; Belman J; Feldman E; Andrise A; Robbs R; Becker R; Kumar V
Alzheimer Dis Assoc Disord; 1992; 6(3):164-81. PubMed ID: 1485931
[TBL] [Abstract][Full Text] [Related]
11. The usefulness of the story recall test in patients with mild cognitive impairment and Alzheimer's disease.
Baek MJ; Kim HJ; Ryu HJ; Lee SH; Han SH; Na HR; Chang Y; Chey JY; Kim S
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2011 Mar; 18(2):214-29. PubMed ID: 21229403
[TBL] [Abstract][Full Text] [Related]
12. Cognition-enhancing effect of vagus nerve stimulation in patients with Alzheimer's disease: a pilot study.
Sjögren MJ; Hellström PT; Jonsson MA; Runnerstam M; Silander HC; Ben-Menachem E
J Clin Psychiatry; 2002 Nov; 63(11):972-80. PubMed ID: 12444809
[TBL] [Abstract][Full Text] [Related]
13. Validation of the Telephone Interview for Cognitive Status (TICS) in Japanese.
Konagaya Y; Washimi Y; Hattori H; Takeda A; Watanabe T; Ohta T
Int J Geriatr Psychiatry; 2007 Jul; 22(7):695-700. PubMed ID: 17431929
[TBL] [Abstract][Full Text] [Related]
14. The validity and reliability of the Turkish version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild and moderate Alzheimer's disease and normal subjects.
Mavioglu H; Gedizlioglu M; Akyel S; Aslaner T; Eser E
Int J Geriatr Psychiatry; 2006 Mar; 21(3):259-65. PubMed ID: 16477580
[TBL] [Abstract][Full Text] [Related]
15. Quantitative characterization of verbal learning deficits in patients with Alzheimer's disease.
Köhler S
J Clin Exp Neuropsychol; 1994 Oct; 16(5):749-53. PubMed ID: 7836498
[TBL] [Abstract][Full Text] [Related]
16. Psychometric evaluation of ADAS-Cog and NTB for measuring drug response.
Karin A; Hannesdottir K; Jaeger J; Annas P; Segerdahl M; Karlsson P; Sjögren N; von Rosen T; Miller F
Acta Neurol Scand; 2014 Feb; 129(2):114-22. PubMed ID: 23763450
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer's disease: correlational analysis of three screening tests and three behavioral scales.
Villardita C; Lomeo C
Acta Neurol Scand; 1992 Dec; 86(6):603-8. PubMed ID: 1481648
[TBL] [Abstract][Full Text] [Related]
18. Top cited papers in International Psychogeriatrics: 6c. Tracking cognitive decline in Alzheimer's disease using the Mini-mental State Examination: a meta-analysis ("mini" is not necessarily trivial!).
Han L
Int Psychogeriatr; 2009 Dec; 21(6):1037-40. PubMed ID: 19747422
[No Abstract] [Full Text] [Related]
19. Instability of cognitive asymmetry in Alzheimer's disease.
Xeno Rasmusson D; Brandt J
J Clin Exp Neuropsychol; 1995 May; 17(3):449-58. PubMed ID: 7650106
[TBL] [Abstract][Full Text] [Related]
20. Cardinal features of cognitive dysfunction in Alzheimer's disease: a factor-analytic study of the Alzheimer's Disease Assessment Scale.
Talwalker S; Overall JE; Srirama MK; Gracon SI
J Geriatr Psychiatry Neurol; 1996 Jan; 9(1):39-46. PubMed ID: 8679062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
